Effect of Grapex on patients with Rheumatoid Arthritis
Not Applicable
- Conditions
- Rheumatoid arthritis.Rheumatoid arthritis, unspecified
- Registration Number
- IRCT20180212038705N3
- Lead Sponsor
- Ahvaz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Age over 18 years
Consent to participate in the study
Patients with rheumatoid arthritis based on ACR 2010 criteria
Moderate to severe disease activity based on Modified DAS28 score
Exclusion Criteria
Duration of diseases more than 5 years
Concomitant use of warfarin
Allergy to grapes and its components,
Presence of any types of malignancy and cancer
Pregnancy
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Disease severity. Timepoint: At baseline and after treatment (8 week). Method of measurement: Modified DAS28 score.;Erythrocyte sedimentation rate (ESR). Timepoint: At baseline and after treatment. Method of measurement: Western Green analysis.;Swollen joint count (SJC). Timepoint: At baseline and after treatment. Method of measurement: Examination and clinical judgment of the physician.;Tender joint count (TJC). Timepoint: At baseline and after treatment. Method of measurement: Examination and clinical judgment of the physician.;CRP. Timepoint: At baseline and after treatment. Method of measurement: Aagglutination test.
- Secondary Outcome Measures
Name Time Method